Revenue
No reported data
ARTELO BIOSCIENCES, INC. (ARTL)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | $5.4M | $6.0M | $5.7M | $4.3M | $2.8M | $1.9M | $1.1M | $1.2M | — | — | — | — |
| Operating expenses | $11.4M | $10.1M | $9.9M | $10.3M | $7.4M | $4.7M | $3.2M | $2.3M | $232,789 | $29,690 | $15,241 | $15,269 |
| Operating income | −$11.4M | −$10.1M | −$9.9M | −$10.3M | −$7.4M | −$4.7M | −$3.2M | −$2.3M | −$232,789 | −$29,690 | −$15,241 | −$15,269 |
| Net income | −$12.9M | −$9.8M | −$9.3M | −$10.1M | −$7.4M | −$4.7M | −$2.2M | −$2.3M | −$234,889 | −$29,690 | −$15,241 | −$15,269 |
| Basic EPSper diluted share | — | — | — | — | -$0.40 | -$1.26 | -$1.00 | -$1.84 | -$0.03 | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | -$12.52 | -$18.30 | -$3.14 | — | -$0.40 | -$1.26 | -$1.46 | -$1.84 | -$0.03 | $0.00 | $0.00 | $0.00 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 1, 2025Form 4 | FAVORITO TAMARA ADirector | BuyConvertible Promissory Note · derivative · indirect | — | $25.0K | $25.0K | — |
| May 1, 2025Form 4 | MATSUI CONNIEDirector | BuyConvertible Promissory Note · derivative | — | $140.0K | $140.0K | — |
| May 1, 2025Form 4 | Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr | BuyConvertible Promissory Note · derivative | — | $35.0K | $35.0K | — |